These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 18839781

  • 1. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC.
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [Abstract] [Full Text] [Related]

  • 2. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394
    [Abstract] [Full Text] [Related]

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
    Lehman DA, Chung MH, John-Stewart GC, Richardson BA, Kiarie J, Kinuthia J, Overbaugh J.
    AIDS; 2008 Jul 31; 22(12):1475-85. PubMed ID: 18614871
    [Abstract] [Full Text] [Related]

  • 6. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC.
    AIDS; 2005 Sep 02; 19(13):1415-22. PubMed ID: 16103773
    [Abstract] [Full Text] [Related]

  • 7. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL.
    JAMA; 2004 Jul 14; 292(2):202-9. PubMed ID: 15249569
    [Abstract] [Full Text] [Related]

  • 8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 14; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 9. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group.
    AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842
    [Abstract] [Full Text] [Related]

  • 10. Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels.
    Slyker JA, Richardson B, Chung MH, Atkinson C, Ásbjörnsdóttir KH, Lehman DA, Boeckh M, Emery V, Kiarie J, John-Stewart G.
    AIDS Res Hum Retroviruses; 2017 Apr 18; 33(4):332-338. PubMed ID: 27796131
    [Abstract] [Full Text] [Related]

  • 11. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
    J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045
    [Abstract] [Full Text] [Related]

  • 12. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 13. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 12; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 14. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M.
    J Med Virol; 2015 Oct 12; 87(10):1662-7. PubMed ID: 25940687
    [Abstract] [Full Text] [Related]

  • 15. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
    Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P, Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L.
    J Acquir Immune Defic Syndr; 2007 Mar 01; 44(3):286-91. PubMed ID: 17146372
    [Abstract] [Full Text] [Related]

  • 16. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar 10; 14(4):367-74. PubMed ID: 10770538
    [Abstract] [Full Text] [Related]

  • 17. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
    Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F, Newell ML, Saba J, Gray G, Ndugwa Ch, Kilewo Ch, Massawe A, Kituuka P, Okong P, Grulich A, von Briesen H, Goudsmit J, Biberfeld G, Haverkamp G, Weverling GJ, Lange JM, Ghent Group on HIV in Women and Children.
    AIDS; 2005 Nov 04; 19(16):1865-75. PubMed ID: 16227795
    [Abstract] [Full Text] [Related]

  • 18. Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis.
    Salado-Rasmussen K, Theilgaard ZP, Chiduo MG, Bygbjerg IC, Gerstoft J, Lüneborg-Nielsen M, Lemnge M, Katzenstein TL.
    PLoS One; 2015 Nov 04; 10(3):e0121111. PubMed ID: 25812161
    [Abstract] [Full Text] [Related]

  • 19. Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
    Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, Makhema J, Moyo S, Thior I, McIntosh K, van Widenfelt E, Leidner J, Powis K, Asmelash A, Tumbare E, Zwerski S, Sharma U, Handelsman E, Mburu K, Jayeoba O, Moko E, Souda S, Lubega E, Akhtar M, Wester C, Tuomola R, Snowden W, Martinez-Tristani M, Mazhani L, Essex M.
    N Engl J Med; 2010 Jun 17; 362(24):2282-94. PubMed ID: 20554983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.